INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 194 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,808,000 | +80.6% | 54,942 | -3.3% | 0.53% | +138.9% |
| Q3 2019 | $3,769,000 | -16.6% | 56,794 | 0.0% | 0.22% | +10.0% |
| Q2 2019 | $4,519,000 | -31.0% | 56,794 | -12.6% | 0.20% | -9.5% |
| Q4 2018 | $6,547,000 | -20.2% | 64,961 | 0.0% | 0.22% | +40.5% |
| Q3 2018 | $8,208,000 | +50.6% | 64,961 | 0.0% | 0.16% | +66.3% |
| Q2 2018 | $5,451,000 | +36.4% | 64,961 | 0.0% | 0.10% | +18.8% |
| Q1 2018 | $3,996,000 | – | 64,961 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |